CAREDX INC (CDNA) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:CDNA • US14167L1035

20.63 USD
+0.21 (+1.03%)
At close: Feb 3, 2026
20.63 USD
0 (0%)
After Hours: 2/3/2026, 8:04:27 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
CDNA revenue by date.CDNA revenue by date.
321.8M
8.57%
280.324M
-12.89%
333.785M
19.07%
382.16M
14.49%
425.41M
11.32%
469.73M
10.42%
551.23M
17.35%
EBITDA
YoY % growth
CDNA ebitda by date.CDNA ebitda by date.
-65.6M
-213.88%
-89.657M
-36.67%
-39.558M
55.88%
36.286M
191.73%
50.241M
38.46%
70.383M
40.09%
109.65M
55.79%
EBIT
YoY % growth
CDNA ebit by date.CDNA ebit by date.
-77.2M
-159.93%
-104.043M
-34.77%
-53.752M
48.34%
19.123M
135.58%
28.12M
47.05%
41.417M
47.29%
56.757M
37.04%
Operating Margin
CDNA operating margin by date.CDNA operating margin by date.
-23.99%-37.12%-16.10%5.00%6.61%8.82%10.30%
EPS
YoY % growth
CDNA eps by date.CDNA eps by date.
-0.39
-234.48%
-0.64
-64.10%
0.54
184.38%
0.71
32.33%
0.93
29.91%
1.26
35.55%
1.97
56.44%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.24
35.43%
0.22
142.37%
0.24
143.48%
0.23
-18.19%
0.23
-6.75%
0.20
-6.48%
0.26
4.73%
0.30
29.14%
0.35
52.56%
Revenue
Q2Q % growth
105.31M
21.63%
102.42M
20.94%
105.81M
22.07%
107.2M
7.14%
109.83M
4.29%
107.67M
5.13%
113.99M
7.73%
115.94M
8.15%
121.73M
10.83%
EBITDA
Q2Q % growth
12.852M
325.51%
12.204M
376.48%
13.625M
495.04%
12.731M
-3.48%
12.863M
0.09%
12.918M
5.85%
16.289M
19.55%
19.532M
53.42%
23.397M
81.89%
EBIT
Q2Q % growth
8.286M
141.65%
5.882M
173.40%
6.941M
164.44%
6.3M
206.72%
7.002M
-15.50%
1.966M
-66.58%
6.444M
-7.16%
9.141M
45.10%
12.853M
83.56%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.28
100.00%
0.140.1493.77%
Q2 2025
Q2Q % growth
0.10
-60.00%
0.12-0.02-18.08%
Q1 2025
Q2Q % growth
0.09
400.00%
0.070.0236.04%
Q4 2024
Q2Q % growth
0.18
205.88%
0.130.0537.26%
Q3 2024
Q2Q % growth
0.14
177.78%
0.010.131,272.55%
Q2 2024
Q2Q % growth
0.25
238.89%
-0.150.40270.21%
Q1 2024
Q2Q % growth
-0.03
72.73%
-0.210.1885.72%
Q4 2023
Q2Q % growth
-0.17
-142.86%
-0.270.1037.44%
Q3 2023
Q2Q % growth
-0.18
-200.00%
-0.400.2255.37%
Q2 2023
Q2Q % growth
-0.18
-38.46%
-0.320.1443.07%
Q1 2023
Q2Q % growth
-0.11
15.38%
-0.110.000.15%
Q4 2022
Q2Q % growth
-0.07
-133.33%
-0.090.0220.39%
Q3 2022
Q2Q % growth
-0.06
-185.71%
-0.140.0857.98%
Q2 2022
Q2Q % growth
-0.13
-218.18%
-0.11-0.02-13.80%
Q1 2022
Q2Q % growth
-0.13
-192.86%
-0.05-0.08-154.90%
Q4 2021
Q2Q % growth
-0.03
-137.50%
0.03-0.06-190.50%
Q3 2021
Q2Q % growth
0.07
-30.00%
0.010.06471.90%
Q2 2021
Q2Q % growth
0.11
175.00%
0.050.06107.39%
Q1 2021
Q2Q % growth
0.14 0.010.132,645.10%
Q4 2020
Q2Q % growth
0.08 0.020.06264.80%
Q3 2020
Q2Q % growth
0.10 -0.040.14330.68%
Q2 2020
Q2Q % growth
0.04 -0.040.08198.04%
Q1 2020
Q2Q % growth
0.00 0.03-0.03-100.00%
CDNA Yearly EPS VS EstimatesCDNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
100.055M
20.72%
97.156M2.899M2.98%
Q2 2025
Q2Q % growth
86.679M
-6.06%
92.43M-5.751M-6.22%
Q1 2025
Q2Q % growth
84.685M
17.54%
86.069M-1.384M-1.61%
Q4 2024
Q2Q % growth
86.579M
32.04%
85.797M782K0.91%
Q3 2024
Q2Q % growth
82.883M
23.35%
82.136M747K0.91%
Q2 2024
Q2Q % growth
92.274M
31.26%
69.218M23.056M33.31%
Q1 2024
Q2Q % growth
72.049M
-6.75%
64.403M7.646M11.87%
Q4 2023
Q2Q % growth
65.569M
-20.41%
64.928M641K0.99%
Q3 2023
Q2Q % growth
67.192M
-15.33%
54.201M12.991M23.97%
Q2 2023
Q2Q % growth
70.301M
-12.81%
63M7.301M11.59%
Q1 2023
Q2Q % growth
77.262M
-2.72%
82.313M-5.051M-6.14%
Q4 2022
Q2Q % growth
82.38M
3.99%
83.293M-913K-1.10%
Q3 2022
Q2Q % growth
79.36M
4.99%
84.274M-4.914M-5.83%
Q2 2022
Q2Q % growth
80.63M
8.68%
83.484M-2.854M-3.42%
Q1 2022
Q2Q % growth
79.42M
17.83%
80.496M-1.076M-1.34%
Q4 2021
Q2Q % growth
79.22M
35.10%
79.657M-437K-0.55%
Q3 2021
Q2Q % growth
75.59M
41.63%
75.528M62K0.08%
Q2 2021
Q2Q % growth
74.19M
77.49%
69.117M5.073M7.34%
Q1 2021
Q2Q % growth
67.4M
75.61%
62.275M5.125M8.23%
Q4 2020
Q2Q % growth
58.64M 56.623M2.017M3.56%
Q3 2020
Q2Q % growth
53.37M 54.069M-699K-1.29%
Q2 2020
Q2Q % growth
41.8M 36.323M5.477M15.08%
Q1 2020
Q2Q % growth
38.38M 38.775M-395K-1.02%
CDNA Yearly Revenue VS EstimatesCDNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS9.06% 16.59% 5.83% 30.95%
Revenue0.79% 0.96% 0.34% 1.57%